Archives

by in
Entry Author Date Location
Futuristic “Human-on-Chip” Models Will Help Drug Development 11/19/13 National
Time to Come Clean: Why A High-Tech Guy Envies the Low-Tech World 11/12/13 Seattle
Red (and Green) Flags To Look for With Biotech’s Buyside Investors 10/31/13 Boston
Pharma Showing Interest in Open Systems for Drug Discovery 10/23/13 National
Science: The Missing Ingredient in the GMO Food Labeling Debate 10/08/13 Seattle
The Human Genome Project Wasn’t Overhyped. The Payoff Just Took Time 10/03/13 National
Seeing Beyond the IPO Window Dressing 10/02/13 San Diego
Biotech CEOs Don’t Know It All. They Need Mentors 09/26/13 San Diego
Foundation’s IPO Isn’t Bubbly, It’s a Jolt for Genomic Diagnostics 09/25/13 Boston
Are Some Degrees Better than Others for Big Pharma Leaders? 09/09/13 Seattle
5 Things Biotechs Should Do to Take Advantage of The Boom 09/05/13 New York
Starting a Company Is Hard. Good Health Insurance Makes It Easier. 08/30/13 Boston
Biotech VCs, Stung by Startup Returns, Elbow into Royalty Financing 08/16/13 Boston
Lost in Translation: The Novice’s Guide to BioPharma Idioms 08/07/13 Seattle
How to Save $200 Billion and Cure Hepatitis C 07/22/13 Boston
Is Crowdfunding The Future For Biomedical Research? 07/11/13 National
Baseball and Biopharma: More Alike Than You Might Realize 07/03/13 Seattle
Constructing Innovation Supply Chains for the Pharmaceutical Industry 06/26/13 Boston
Can’t Get No Respect? Bio-venture Issues Are Deeper Than Paper Gains 06/25/13 San Diego
We Owe it to Patients to Provide a Reliable Supply of Medicines 06/04/13 National
Why Not Test a Supply Chain Model? What We’ve Got Isn’t Working 05/31/13 San Diego
Assigning Credit and Blame to Biopharma R&D Chiefs 05/29/13 Seattle
Applying “Innovation Arbitrage” to Develop Novel Medicines in China 05/28/13 San Diego
Why the Kendall Square Lab and Office Markets Are Out of Whack 05/15/13 Boston
Supply Chains Are Orderly. Biotech Innovation Is Messy 04/30/13 Boston
Boston: Reclaiming Its Place as a Technology Hub 04/26/13 Boston
Can Biotech Learn From the TV Production Market? 04/26/13 National
The Devil is in the Details: What BioPharma Press Releases Don’t Say 04/24/13 Seattle
From Assets to Zen: Building Successful Drug Hunting Relationships 04/22/13 San Diego
Re-thinking Clinical Trials for the World of Crowdsourcing 04/16/13 Boston
Page 3 of 10 « previous page · next page »